Published in Lancet on May 05, 1962
Fusidic acid cream in the treatment of impetigo in general practice: double blind randomised placebo controlled trial. BMJ (2002) 5.01
Comparative study of mupirocin and oral co-trimoxazole plus topical fusidic acid in eradication of nasal carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1995) 2.14
In vitro activities of teichomycin, fusidic acid, flucloxacillin, fosfomycin, and vancomycin against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1984) 1.51
Fusidic acid: laboratory and clinical assessment. Br Med J (1962) 1.28
Treatment of staphylococcal infections with "fucidin". Br Med J (1963) 1.21
Fusidic acid: new opportunities with an old antibiotic. Can Med Assoc J (1980) 1.21
Interaction of albumin and fusidic acid. Br J Pharmacol (1971) 1.12
Naturally-occurring fusidic acid resistance in staphylococci and its linkage to other resistances. J Clin Pathol (1966) 1.09
In vitro activities of ceftriaxone and fusidic acid against 13 isolates of Coxiella burnetii, determined using the shell vial assay. Antimicrob Agents Chemother (1993) 1.07
Compensatory adaptation to the loss of biological fitness associated with acquisition of fusidic acid resistance in Staphylococcus aureus. Antimicrob Agents Chemother (2005) 1.04
Antimicrobial activity of fusidic acid and disk diffusion susceptibility testing criteria for gram-positive cocci. J Clin Microbiol (1995) 1.01
Wound healing in rats with the antibiotic Fucidin. Br J Pharmacol Chemother (1962) 0.96
METABOLIC EFFECTS OF THE STEROID ANTIBIOTIC FUSIDIC ACID. Br Med J (1965) 0.95
A new strategy to fight antimicrobial resistance: the revival of old antibiotics. Front Microbiol (2014) 0.94
Fucidin in patients on haemodialysis. J Clin Pathol (1970) 0.94
The use of fusidic acid gel in pilonidal abscess treatment: cure, recurrence and failure rates. Ann R Coll Surg Engl (1986) 0.89
The disposition of sodium fusidate in man. Br J Clin Pharmacol (1977) 0.89
CANDIDA ENDOCARDITIS AFTER CARDIAC SURGERY. Br Med J (1963) 0.89
Update on fusidic acid (CEM-102) tested against Neisseria gonorrhoeae and Chlamydia trachomatis. Antimicrob Agents Chemother (2010) 0.87
Concentrations of fusidic acid, cloxacillin, and cefamandole in sera and atrial appendages of patients undergoing cardiac surgery. Antimicrob Agents Chemother (1985) 0.86
In vitro activity of sodium fusidate against anaerobic bacteria. Antimicrob Agents Chemother (1979) 0.84
Mutations in fusA associated with posttherapy fusidic acid resistance in Clostridium difficile. Antimicrob Agents Chemother (2007) 0.82
Comparison of susceptibility of Neisseria meningitidis to sodium sulphadiazine and sodium fusidate in vitro. J Clin Pathol (1978) 0.78
Fucidin, A New Antibiotic. Can Med Assoc J (1962) 0.75
Antiviral activity of sodium fusidate and related compounds. Br J Pharmacol Chemother (1967) 0.75
Fusidic acid: a new antibiotic. Nature (1962) 1.80
Investigations into the toxicity of benzylpenicillin-beta-diethylaminoethyl ester. Acta Pharmacol Toxicol (Copenh) (1953) 1.02
Tebamin: a derivative of p-aminosalicylic acid; blood levels, absorption and excretion following oral administration. Acta Pharmacol Toxicol (Copenh) (1957) 0.87
[Calcipen Leo, a new peroral penicillin preparation]. Ugeskr Laeger (1956) 0.79
KINETICS OF SERUM AMINOSALICYLIC ACID LEVELS. Br J Pharmacol Chemother (1964) 0.75
The renal clearance of pantothenic acid in man. Scand J Clin Lab Invest (1951) 0.75
[Not Available]. Nord Med (1949) 0.75
Effect of benzoic acid and benzoic acid derivatives on the growth of Streptobacterium plantarum and Saccharomyces cerevisiae. Cr Trav Lab Carlsberg Ser Physiol (1946) 0.75
Inactivation of benzylpenicillin-beta-diethylaminoethyl ester hydriodide in the blood. Scand J Clin Lab Invest (1953) 0.75
Centyl (bendroflumethiazide). Experimental studies on a new oral diuretic. J Ir Med Assoc (1960) 0.75
Antivitamin effect of sulfanilamide on Streptobacterium plantarum. Cr Trav Lab Carlsberg Ser Physiol (1946) 0.75
[Fucidin, a new antibiotic for peroral therapy]. Ugeskr Laeger (1962) 0.75
Tuberculostatic properties of p-aminosalol (phenyl-p-aminosalicylate). Acta Pharmacol Toxicol (Copenh) (1955) 0.75
Tuberculostatic properties of p-aminosalol (phenyl-p-aminosalicylate) derivatives. Acta Pharmacol Toxicol (Copenh) (1953) 0.75
A note on the stability of the trifluoromethyl group of bendroflumethiazide in rats. J Pharm Pharmacol (1963) 0.75
Antivitamin effect of sulfanilamide on Saccharomyces cerevisiae. Cr Trav Lab Carlsberg Ser Physiol (1946) 0.75
Antibiotic properties of picromycin. Acta Pharmacol Toxicol (Copenh) (1953) 0.75
Antivitamins for pantothenic acid. Acta Pharmacol Toxicol (Copenh) (1945) 0.75
Effect of marfanil on Streptobacterium plantarum, Saccharomyces cerevisiae and Aspergillus niger. Cr Trav Lab Carlsberg Ser Physiol (1946) 0.75